Microbiology & Pathology

MilliporeSigma is a global life sciences supplier offering laboratory chemicals, consumables, equipment, and services for research, biomanufacturing, and analytical testing. The company operates under multiple brand portfolios: Sigma-Aldrich provides research chemicals, solvents, reagents, reference materials, and labware; Millipore specializes in filtration products, membrane technologies, and biopharmaceutical manufacturing solutions; SAFC supplies pharmaceutical and biopharmaceutical raw materials; Supelco offers analytical chromatography products and standards; Milli-Q provides laboratory water purification systems and consumables; and BioReliance delivers contract testing and quality assurance services. Product lines include certified reference materials, microbial culture media, syringe filters, centrifugal devices (Amicon), filter membranes, pipette tips, glassware, cell separation media, water purification cartridges, and bioprocessing platforms. MilliporeSigma serves pharmaceutical development, biomanufacturing, clinical diagnostics, food and beverage testing, and academic research markets. The company emphasizes sustainability initiatives, offering greener alternative products and returnable solvent systems (ReCycler). Services include consultative workflow optimization and contract manufacturing support. Operations span multiple locations with comprehensive global distribution and customer support infrastructure.

DIESSE Diagnostica Senese S.p.A. is an Italian manufacturer of in vitro diagnostic (IVD) systems headquartered in Siena, specializing in immunochemistry, infectious disease diagnostics, autoimmune testing, and automated erythrocyte sedimentation rate (ESR) measurement. Founded in the 1980s, the company operates as a research-focused Società Benefit with over 180 employees and exports to more than 100 countries. DIESSE manufactures a comprehensive portfolio of automated and manual diagnostic solutions including the CHORUS EVO platform for immunochemistry, VES-MATIC 5 for ESR analysis with AI integration, AUTO-DAT for standardized seroagglutination testing, Enzywell for manual immunochemistry, and iRapid for rapid immunodiagnostics. All products are produced in-house in Italy, emphasizing quality, sustainability, and ethical practices. The company serves clinical laboratories, hematology centers, and infectious disease diagnostics facilities globally.

NEST Scientific is a worldwide manufacturer and distributor of high-quality plastic laboratory consumables and cell culture vessels, serving research institutions, clinical laboratories, and industrial biotech facilities across North America, Europe, Asia, and beyond. Founded in 2009 with manufacturing operations in Wuxi, China and distribution from Woodbridge, New Jersey, NEST maintains ISO 9001:2008, ISO 13485, CE, and FDA registration certifications. The company operates a high-precision manufacturing facility featuring ISO 8 grade cleanrooms, state-of-the-art injection molding equipment, and in-house E-Beam sterilization capabilities. NEST offers over 200 sterile and non-sterile plastic products including cell culture flasks and plates, centrifuge tubes, PCR plates, pipette tips, cryogenic vials, serological pipettes, and nasal drug delivery devices. Products serve molecular biology, immunoassay, liquid handling, qPCR/PCR, and bioprocessing applications.

Sebia Autoimmune & Infectious Diseases (formerly ZEUS Scientific) is a US-based in vitro diagnostic (IVD) company with 45+ years of clinical diagnostics expertise. Founded in 1976 and acquired by Sebia in October 2022, the company develops, manufactures, and markets high-quality immunoassays for autoimmune disorders and infectious diseases. ZEUS Scientific offers a portfolio of over 125 FDA-cleared assays utilizing Indirect Fluorescent Antibody (IFA) and Enzyme Immunoassay (EIA) technologies. Key products include automated IFA slide processing systems and digital immunofluorescence imaging solutions. The company provides comprehensive contract manufacturing, OEM partnerships, and custom diagnostic solutions. With deep expertise in immunofluorescence imaging, flow cytometry, and clinical protein electrophoresis, ZEUS Scientific supports hospital laboratories, clinical research organizations, and diagnostic manufacturers globally with workflow automation and quality assurance.

DiaPharma Group, Inc. manufactures specialty research and clinical assay kits, reagents, and hemostasis analyzers for bleeding/clotting disorders, thrombosis, liver disease, drug-induced organ injury, and anti-cancer drug development. Founded in 1997, the company employs scientists with expertise in hemostasis, coagulation testing, platelet function analysis, fibrosis biomarkers, and NETosis research. DiaPharma offers chromogenic substrates, ADAMTS13 assays, Factor X testing, and mechanistic biomarkers for MASH, alcoholic liver disease (ALD), and drug-induced liver injury (DILI). The company provides personalized scientific support and customer service to clinical laboratories, research institutions, and pharmaceutical development teams.

Medix Corporation is a comprehensive medical supply distributor based in Thousand Oaks, California, serving laboratories, healthcare facilities, and government agencies. The company operates an extensive catalog spanning laboratory safety equipment, clinical laboratory consumables, microbiology supplies, and physician-grade medical supplies. Product lines include microscopes, pipettes, culture media, sterilization equipment, PPE (gloves, masks, respirators), gauze and dressings, syringes and needles, surgical instruments (scalpels, forceps, sutures), phlebotomy supplies, and laboratory chemicals. Medix serves clinical laboratories, hospitals, educational institutions, and government entities at federal, state, and local levels. The company offers online ordering, telephone, fax, and email ordering options with monthly specials and a customer service team dedicated to order accuracy and satisfaction.

Biorex Labs manufactures specialized reagents and consumables for clinical microbiology laboratories worldwide. The company produces a comprehensive range of diagnostic products including fluorescence stains (MYCOLAST Red and Blue), rapid chromogenic tests in dry format (XeroStrips), reagents in disposable dropper format (MicroDrops), enrichment media, and rapid identification strips. Product lines include ketone testing controls and tablets, urinalysis reagents (bilirubin testing), rapid urease strips, oxidase and indole test strips, pyruvate utilization (PYR) test strips, fungal staining and mounting media, culture preservation systems (CryoBac vials), and TB/AFB processing reagents. All products are designed for high-sensitivity detection and rapid turnaround in clinical laboratory settings. Distribution through major healthcare suppliers including Thermo Fisher, Cardinal Health, and Medline.

pfm medical gmbh is a family-owned medical technology manufacturer based in Cologne, Germany, established in 1971. The company develops, manufactures, and distributes approximately 1,800 specialized medical products across four main therapeutic areas: surgery, cardiovascular technologies, histotechnology, and infusion solutions. Key product lines include DURAMESH™ suturable meshes for breast reconstruction and pelvic floor surgery, Nit Occlud® spiral systems for cardiac defect closure, and advanced histology laboratory equipment including the award-winning pfm Forceps EWF 600 wireless heated forceps and the Samui® cooling plate for tissue sample preparation. The company also offers intraoperative imaging solutions such as the ClearCoast™ MRI system for real-time tissue analysis during breast conservation procedures. With over 50 years of operational experience, pfm medical operates 12 locations across 8-10 countries and exports to more than 100 markets worldwide. The company provides comprehensive customer support including compliance training, user education, and technical services to healthcare facilities, medical practices, laboratories, nursing services, and home care providers.

Nisene Technology Group is the world leader in automated integrated circuit (IC) decapsulation solutions, serving the semiconductor failure analysis and counterfeit detection industries for over six decades. The company specializes in precision decapsulation equipment designed to safely open IC packages while preserving wire bonds and device functionality for detailed failure analysis, reliability testing, and counterfeit component detection. Nisene offers three primary decapsulation technologies: chemical-based JetEtch systems (including CuProtect and TotalProtect variants with patented copper wire protection), microwave-induced plasma (MIP) PlasmaEtch for eco-friendly dry decapsulation of sensitive devices, and laser-based LaserEtch for pre-cavitation work. The company's systems support multiple wire types (copper, gold, aluminum, copper-palladium) and are trusted by major semiconductor manufacturers, distributors, aerospace, defense, and automotive electronics firms globally. Nisene emphasizes reliability, precision, safety compliance, and comprehensive applications support.

Pentapharm AG is a Swiss manufacturer of active pharmaceutical ingredients (APIs), diagnostic reagents, and biochemical products founded in 1948 and headquartered in Aesch, Basel-Landschaft. Specializing in hemostasis, coagulation, and anticoagulation therapies, the company supplies the pharmaceutical and diagnostic industries with naturally derived APIs including Aprotinin, Batroxobin, and Haemocoagulase—all supported by Drug Master Files (DMFs) and CEP certificates. The company manufactures standardized biochemicals for research, quality control, and analytical applications; highly purified snake venom enzymes for plasma coagulation and fibrinolysis modulation; proteinase inhibitors for proteolytic control; and synthetic peptide substrates (chromogenic, fluorogenic, amperogenic) for diagnostic assay development and proteinase activity monitoring. Pentapharm also develops and produces in-vitro diagnostic (IVD) reagent kits and research-use-only (RUO) kits for coagulation and fibrinolysis analysis. All manufacturing operates under GMP standards with strong emphasis on regulatory compliance, quality assurance, and accelerated time-to-market for partner pharmaceutical and diagnostics companies.

ABOUND Diagnostics, Inc. is a San Diego-based in vitro diagnostic (IVD) manufacturer specializing in rapid diagnostic tests and point-of-care testing (POCT) products for both human and veterinary health markets. The company offers a comprehensive portfolio including rapid tests for women's health, drugs of abuse, infectious diseases, tumor markers, and cardiac markers; blood glucose monitoring systems (VivaGuard® Ino, VQ PET H); lancing devices and lancets; infrared thermometers; urinalysis and biochemistry reagent strips; and fluorescence immunoassay (FIA) and chemiluminescence immunoassay (CLIA) test kits. ABOUND serves US and international markets, with a mission to deliver high-quality, affordable diagnostic solutions that improve healthcare access globally.

Lonza is a Swiss multinational contract development and manufacturing organization (CDMO) founded in 1897, headquartered in Basel. The company operates 30+ development and manufacturing sites globally and employs approximately 20,000 colleagues across five continents. As the pioneer and world leader in the CDMO industry, Lonza specializes in biopharmaceutical manufacturing and offers integrated services across biologics development, mammalian cell culture systems, small molecules and highly potent active pharmaceutical ingredients (HPAPIs), bioconjugates, cell and gene therapies (CGT), advanced mRNA technologies, and specialized modalities. The company also manufactures pharmaceutical capsules and health ingredients for nutraceutical applications. Lonza provides end-to-end support from drug development through manufacturing and commercialization, serving major pharmaceutical and biotechnology customers globally. Notable partnerships include production collaboration with Moderna for COVID-19 vaccine manufacturing.

MetaMol Theranostics develops a breakthrough diagnostic test for breast cancer risk assessment. The company has identified and validated hOPN-c (osteopontin-C), a protein biomarker that indicates elevated breast cancer risk when detected in breast biopsy samples. Pathologists can apply this test to biopsy specimens to quantify cancer risk, enabling women with breast lumps to make informed treatment decisions. The test delivers risk stratification at a critical clinical decision point, addressing the significant financial and emotional burden of unnecessary breast cancer interventions. MetaMol's diagnostic platform targets pathology laboratories and oncology centers, providing clinical evidence to guide patient management and treatment planning.

SoftWave TRT is a biomedical device manufacturer specializing in FDA-cleared electrohydraulic shockwave therapy systems for tissue regeneration, pain relief, and healing. Founded in 2004 and headquartered in Kennesaw, Georgia, the company has developed over 30 patents for its proprietary SoftWave® technology, which uses spark-initiated acoustic shockwaves to activate cellular healing responses including stem cell activation and improved blood flow without microtrauma. The flagship OrthoGold device and SoftWave Gold Li-Series platform are designed for orthopedic conditions, musculoskeletal pain, chronic diabetic foot ulcers, acute and chronic wounds, burns, and urological/pelvic health applications. The broad-focused, parallel-dispersion shockwave technology delivers results in 10–15 minute sessions with no downtime, and is deployed across leading medical institutions, university hospitals (Mayo Clinic, UCSF, UPMC), and professional sports organizations (MLB, NFL, NBA, NHL, MLS, NCAA, PGA, UFC). SoftWave TRT serves clinicians in sports medicine, orthopedics, wound care, physical therapy, chiropractic, dermatology, and integrative medicine practices.

PAN-Biotech GmbH is a leading German manufacturer of high-quality cell culture products and biopharmaceutical reagents. Founded in 1988 and headquartered in Aidenbach, Bavaria, the company specializes in media, sera, serum-free systems, biologicals, and reagents for research, biotechnology, and pharmaceutical applications. Certified under GMP, ISO 9001:2015, and FDA-registered, PAN-Biotech delivers "Made in Germany" solutions tailored for cell and gene therapy, vaccine production, mRNA technology, and antibody production. The product portfolio encompasses classical and serum-free media, high-quality sera, specialized reagents for DNA/RNA pharmaceuticals, buffer solutions, and advanced formats for scalable upstream and downstream bioprocessing. The company serves biopharmaceutical manufacturers, contract development and manufacturing organizations (CDMOs), and research institutions globally, supporting the development of modern therapeutics with compliant, efficient, and scientifically rigorous products.

UTAK Laboratories Inc. is a family-owned manufacturer specializing in high-quality quality control (QC) materials for clinical, forensic, and reference testing laboratories. Founded in 1973 by toxicology chemist Larry Plutchak and headquartered in Valencia, California, UTAK has served clients in 29 countries for over 50 years. The company manufactures both stock QC materials and custom-designed controls using 100% real human matrices including urine, blood, serum, oral fluid, and hair. UTAK offers products for therapeutic drug monitoring, toxicology, drugs of abuse testing, and specialized analyte panels. The company positions itself as an independent QC partner that eliminates the need for labs to establish internal manufacturing, reducing compliance risk, overhead, and labor burden while providing audit-ready documentation, certificates of analysis, and stability data. Rapid turnaround (approximately 15 days for custom formulations) and conversion of successful formulations to stocked inventory support recurring supply relationships. UTAK serves university hospitals, medical centers, forensic labs, and reference laboratories, including tier-one clients such as Quest Diagnostics.

Sanders Medical Products Inc manufactures calibration sources and quality control solutions for Positron Emission Tomography (PET) and nuclear medicine imaging equipment. Since 1994, the company has specialized in PET sources approved by all major scanner manufacturers including Siemens, GE Healthcare, Philips, Concorde, Hamamatsu, Positron, and Shimadzu. Sanders Medical provides proprietary calibration sources designed to ensure scanner consistency and imaging quality, along with comprehensive services for PET facility maintenance and scanner normalization. The company offers lifetime warranty on sources and maintains a dedicated focus on medical imaging calibration and quality assurance.

Hans Biomed Corp. is a Seoul-based global leader in regenerative medicine and tissue engineering, pioneering acellular dermis processing technology and human tissue transplant products. The company specializes in biologics (bone and skin grafts), silicone breast implants, PDO lifting threads, hair transplantation devices, and scar treatment solutions. With a portfolio spanning medical devices and aesthetic medicine, Hans Biomed exports to over 100 countries and maintains seven overseas subsidiaries. The company operates dedicated research centers—a tissue engineering institute and advanced medical device R&D facility—supporting continuous innovation. Recent product launches include the Bounce silicone breast implant line and Cellderm (ECM-based skin booster), expanding its presence in aesthetic and regenerative medicine markets. Hans Biomed is Korea's first domestically successful breast implant manufacturer and is expanding manufacturing capacity to support growing global demand, particularly in Japan and emerging markets.

C.G. Laboratories, Inc. is a multi-service medical device contract manufacturer and testing laboratory founded in 1983 and headquartered in Granbury, Texas. The company specializes in medical device decontamination, contract packaging, laboratory testing, sterilization validation, and environmental monitoring. With over 40 years of operational experience and 19,000 square feet across two facilities, C.G. Labs serves the medical device, tissue, and dental industries. The company is FDA-registered and ISO 13485:2016 and MDSAP accredited. Core competencies include microbiological analysis, regulatory testing, reusable medical device validation, water testing, air microbial monitoring, and IFU development. C.G. Labs offers customizable decontamination and sterilization services with turnaround times exceeding 72-hour performance objectives, end-to-end contract packaging (sterile and non-sterile), and comprehensive validation support including process validation and equipment qualification. The laboratory team collectively has over 90 years of medical device industry experience.

Esco Lifesciences Group is a world-leading manufacturer of laboratory and biopharma equipment, biological safety cabinets, and IVF medical devices, headquartered in Singapore since 1978. The company serves over 100 countries with a diversified portfolio spanning clinical diagnostics, pharmaceutical manufacturing, bioprocessing, and assisted reproductive technology (ART). Core product lines include CO₂ incubators (CelCulture® Touch series), temperature-controlled shakers (OrbiCult™), biosafety cabinets, fume hoods (Frontier Duo series), PCR cabinets, ultra-low freezers, and cryogenic storage systems. Esco also operates Esco Aster, a CDMO providing contract manufacturing and process development services across upstream/downstream bioprocessing, formulation, and filling. The company employs over 1,700 staff across multiple R&D and manufacturing sites, offering comprehensive support including installation, certification, training, maintenance, and decommissioning services. Applications span pharmaceutical QC, clinical diagnostics, food microbiology, cell therapy, gene therapy, medical device assembly, and biocontainment for BSL-3/4 research.

OSSVIS (operating as Lilivis) is a digital dentistry solutions provider specializing in integrated CAD/CAM systems and same-day dental restoration technology. The company manufactures a complete portfolio of dental imaging, design, production, and milling equipment for dental clinics and laboratories. Core offerings include intraoral scanning systems (Lilivis SCAN), CAD/CAM design software, 3D printing technology (Lilivis PRINT), and precision milling systems (Lilivis MILL) that enable one-day dental restoration workflows. Additional product lines include dental implant systems, surgical kits, and OCT imaging. OSSVIS distributes globally through a network of regional partners across North America, Europe, Asia, and the Middle East, serving dentists, dental laboratories, and dental assistants with high-speed adaptive MSLA printing, dual-processing milling, and chairside design/CAM software.

Zymo Research Corp is a biotechnology company founded in 1994, specializing in molecular biology tools and services. Based in Irvine, California, the company focuses on DNA and RNA purification, epigenetics, microbiomics, and next-generation sequencing (NGS). With approximately 116 employees and annual revenue of $22.8 million, Zymo Research has established a global presence with six international facilities and a wide distribution network. The company emphasizes simplicity in science through its philosophy of 'The Beauty of Science is to Make Things Simple.' Zymo Research prioritizes customer feedback to develop innovative technologies that enhance scientific workflows. Their product offerings include sample preservation solutions (DNA/RNA Shield), comprehensive sequencing and analysis services, advanced purification technologies (Direct-zol, ZymoPURE, Quick-DNA/RNA kits), epigenetics tools (EZ DNA Methylation, bisulfite sequencing), and microbiome standards. Zymo serves academia, healthcare, and industry globally, collaborating with institutions to support scientific research and innovation.

SURU International PVT LTD is a medical device manufacturer and exporter based in Dahanu, Maharashtra, India. The company specializes in the design, manufacture, and distribution of a comprehensive range of medical disposable devices and supplies. With ISO 13485:2016 certification and US FDA approval, SURU serves hospitals, clinics, and healthcare facilities globally through B2B supply chains. The company manufactures critical products across multiple clinical specialties including airway management, biopsy systems, blood bank systems, cardiology devices, dialysis equipment, gastroenterology supplies, gynecological instruments, infusion and transfusion therapy systems, regional anesthesia kits, respiratory care equipment, surgical sutures and mesh, wound care products, and urology devices. SURU offers OEM services and maintains regulatory compliance with international standards. The company actively participates in major international medical trade shows including Arab Health, FIME, and MEDICA, indicating strong export presence and commitment to global market expansion.

Eagle Biosciences, Inc. is a specialized life sciences reagent supplier focusing on immunological and molecular biology products. The company specializes in ELISA assays, MHC (Major Histocompatibility Complex) reagents, and loadable MHC tetramers and monomers for research applications. Eagle Biosciences offers a boutique approach to product sourcing, providing customized solutions including host cell protein detection assays, HLA-peptide complexes, and MHC class I and II reagents for immunology research. The company maintains an extensive catalog of pre-configured peptide-MHC products and offers custom product research and sourcing services for laboratory and clinical research institutions.

Dental Plus USA is a B2B dental equipment and supplies distributor specializing in digital dentistry solutions and dental laboratory automation. The company offers a comprehensive range of products including intraoral scanners (Shining 3D Aoralscan series), zirconia milling blanks and multi-chroma discs, CAD/CAM supplies, polishing and restoration kits, and 3D printing solutions for dental labs. Dental Plus USA prioritizes quality products, professional education, and customer support for dental practices and laboratories transitioning to digital workflows. The company provides educational content on topics including composite bonding to zirconia, CAD/CAM technology implementation, and dental practice management modernization.

VERICOM Co., Ltd. is a South Korean dental materials and medical device manufacturer established in 1998. The company specializes in three primary product categories: dental materials for dental professionals, laboratory materials for dental technicians, and digital materials for digital professionals. Their portfolio includes endodontic sealers (Well-Root ST/PT), hybrid ceramics (MAZIC Duro), resin cements (U-Cem Premium), temporary restoration materials (MAZIC D Temp/SG), and 3D printing systems (MAZIC L-200, MAZIC C-200). VERICOM also offers auto-mixing dispensing equipment and restorative materials (DenFil). The company maintains an active global presence through participation in major international dental exhibitions including IDS Cologne, AEEDC Dubai, and various regional dental conferences. VERICOM has received recognition including a Presidential Award for medical device innovation and maintains an R&D center focused on advancing dental material technology and biocompatibility standards.

ASG Superconductors S.p.A. is an Italian leader in superconducting magnet design, manufacturing, and cryogenic systems for medical, scientific research, high-energy physics, and industrial applications. Founded in 2001 and based in Genoa, the company operates three specialized units: Magnets & Systems (particle accelerators, fusion research magnets), Columbus MgB2 (magnesium diboride superconducting wires for energy transmission and storage), and Paramed MRI (open and helium-free MRI systems). ASG manufactures advanced superconducting magnets for CERN, ITER fusion projects, and proton therapy systems, while Paramed MRI has deployed over 20 MROpen EVO systems globally—the industry's only truly open MRI platform enabling multi-position scanning (standing, sitting, bending, lying). The company's MgB2 technology delivers zero-loss energy transmission solutions and cryogen-free operation, positioning ASG as a key innovator in sustainable superconducting technology with strategic partnerships across global research and medical institutions.

Cancer Diagnostics, Inc. (CDI) is a specialized manufacturer and supplier of anatomical pathology products serving the global surgical pathology, histology, cytology, and immunohistochemistry markets. Founded in 1998, CDI developed the first commercially available 7-dye color kit for cancer margin identification and has grown to serve over 6,000 customers worldwide. The company manufactures a comprehensive range of histology consumables and equipment including tissue marking dyes, microtome blades (Katana™ brand), trimming knives, embedding supplies, ceramic base molds, stainers, embedding centers, slide printers, paraffin dispensers, fixatives, and tissue processing equipment. CDI operates under FDA CGMP standards and is recognized as one of the industry's largest providers of anatomical pathology supplies, supporting surgical specimen preparation, tissue processing, and diagnostic analysis workflows in hospital and independent laboratories globally.

MD Labs is an independent clinical laboratory based in Reno, Nevada, specializing in high-complexity toxicology and pharmacogenetics testing since 2011. The laboratory provides comprehensive testing services for pain management and substance use disorder treatment across the United States. MD Labs utilizes advanced analytical technologies including UPLC-MS/MS/MS for quantitative confirmatory toxicology testing and RT-qPCR for molecular diagnostics, delivering results within 1–2 business days. Services include urine and oral fluid toxicology testing with precise drug detection and quantification, pharmacogenetics (PGx) testing for medication metabolism analysis, and clinical training support for healthcare providers. The lab is CAP-accredited and CLIA-certified, ensuring full compliance with federal and state regulations. MD Labs serves over 14 years of experience providing reliable, actionable laboratory data to clinical practices nationwide.

Giles Scientific Inc is a US-FDA registered device manufacturer and ISO 13485 certified company specializing in microbiology imaging systems for clinical and pharmaceutical laboratories. The company designs and manufactures automated systems for microbiology testing with a customer base spanning 100+ countries. Their core offerings include BIOMIC V3, an open clinical microbiology platform for automating reading and CLSI/EUCAST interpretation of laboratory tests with specialized modules for antimicrobial resistance (AMR) monitoring, and TRINITY V3, an industrial microbiology system for automated zone reading and calculations in USP 81, EP, and JP antibiotic potency assays with full 21 CFR Part 11 compliance. Giles Scientific also supplies consumables including penicillin cylinders and dispensers for antibiotic potency testing.

PathPresenter is an enterprise-grade digital pathology image management and workflow platform founded in 2017 by Dr. Rajendra Singh, a dermatopathologist and digital pathology pioneer. The platform serves pathologists and medical institutions with FDA 510(k)-cleared and CE-IVDR certified clinical viewers for primary diagnosis and consultations. PathPresenter offers comprehensive modules including clinical care, enterprise education, biorepository management for research data, and remote consultation capabilities via ConsultConnect. The system emphasizes vendor-agnostic interoperability, supporting any scanner, storage platform, laboratory information system (LIS), and third-party AI models. Key features include optimized pathologist workflows, voice control integration, powerful slide administration, and seamless integration across institutional systems. With over 50,000 users across 172 countries and adoption by more than 50 top-tier hospitals, laboratories, and pharmaceutical companies, PathPresenter combines clinical performance with AI readiness, enterprise integration, and education leadership. The platform powers the College of American Pathologists' AI Studio, enabling testing of cutting-edge AI tools in realistic scenarios with whole slide images.

Seikagaku Corporation is a pharmaceutical manufacturer and research-driven biotech company headquartered in Tokyo, specializing in glycoscience-based therapeutics. The company develops and manufactures pharmaceutical active ingredients, particularly sodium hyaluronate and chondroitin sulfate ester sodium, used in joint health treatments and medical devices. Core business segments include pharmaceutical APIs (active pharmaceutical ingredients), contract manufacturing/CDMO services for biopharmaceutical partners, and LAL (Limulus Amebocyte Lysate) test reagents for pharmaceutical safety testing. The company maintains robust R&D capabilities in drug development, with regulatory approvals and pipelines in joint injections (SI-449 adhesion prevention material) and other glycoscience-derived therapeutics. Seikagaku operates as a B2B supplier to hospitals, pharmaceutical manufacturers, and clinical research institutions worldwide, with emphasis on regulatory compliance and quality assurance.

Alpinion Medical Systems is a South Korea-based manufacturer of diagnostic and therapeutic ultrasound systems founded in 2007. The company specializes in designing and manufacturing a comprehensive ultrasound portfolio comprising 11 diagnostic ultrasound systems, six types of proprietary transducers utilizing single crystal technology, and the ALPIUS 900 HIFU (High-Intensity Focused Ultrasound) platform for therapeutic applications. Its diagnostic X-CUBE series delivers advanced imaging solutions tailored for internal medicine, obstetrics/gynecology, and cardiology applications. The ALPIUS 900 platform provides non-invasive treatment options for uterine fibroids and adenomyosis. Alpinion integrates AI-powered intelligent technologies throughout the ultrasound workflow—from screening and early detection to diagnosis and reporting—to enhance clinical efficiency and diagnostic confidence. The company maintains a global presence with offices in the USA, Germany, and China, and operates through a network of distributors across 80+ countries.

Maine Molecular Quality Controls, Inc. (MMQCI) is a specialized manufacturer of quality control reagents and panels for molecular diagnostics laboratories. The company produces high-caliber controls designed to monitor all phases of nucleic acid testing procedures, ensuring accuracy and reliability in diagnostic results. MMQCI's product portfolio includes respiratory pathogen controls (COVID-19, influenza, RSV), tropical fever panels, and gastrointestinal pathogen detection controls. The company is ISO 13485:2016 certified, demonstrating compliance with medical device quality management standards. MMQCI's controls are engineered to support clinical laboratories in meeting best-practice standards and regulatory requirements for molecular testing across viral, bacterial, and parasitic pathogen detection.

Polysciences, Inc. is a manufacturer of specialty chemicals and life sciences reagents headquartered in Warrington, Pennsylvania. Founded in 1961, the company supplies ultrapure polymers, microparticles, and fine chemicals for diagnostics, medical devices, biotechnology, and contract manufacturing. Core product lines include poly(acrylic acid), polylactic acid (PLA/PDLA/PLLA), poly(ethylene glycol) derivatives, and microspheres. The company serves bioprocessing, electronic chemicals, materials science, and life sciences markets. Polysciences operates cGMP-compliant manufacturing facilities in the US and offers custom synthesis, contract manufacturing (from pilot to production scale), and analytical support. ISO 13485-certified with cleanroom production capabilities, the company handles hazardous materials and provides blending, milling, filling, and packaging services. Also operates Kyfora Bio, a dedicated bioprocessing brand for cell and gene therapy development.

PatSnap is an AI-driven innovation intelligence platform providing R&D and intellectual property (IP) insights from over 2 billion structured data points covering patents, scientific literature, litigation, and tech sectors. Founded in Singapore and serving 18,000+ organizations globally, PatSnap enables faster innovation (75% faster at 25% less cost) through advanced analytics, patent analysis, competitive intelligence, and design FTO assessments. The platform offers AI agents for IP, engineering, life sciences, and materials domains, with specialized modules including biosequence search (Bio), chemical structure analysis (Chemical), and biopharma intelligence (Synapse). Available as cloud or on-premises deployment, PatSnap supports law firms, life sciences companies, and high-tech enterprises in accelerating decision-making, protecting IP portfolios, and optimizing R&D efficiency.

Kamiya Biomedical Company manufactures clinical diagnostics assay reagents, research ELISAs, antibodies, and biochemicals for laboratory and preclinical use. Primary product lines include immunoassay and immunoturbidimetric reagents adapted to most major automated chemistry analyzers (Roche Cobas, Hitachi, Beckman, Olympus, Siemens, Abbott, and others), spanning rheumatoid factor, C-reactive protein, D-dimer, ferritin, immunoglobulins, β-2 microglobulin, microtransferrin, vitamin C, apolipoprotein assays, H. pylori testing, and KL-6 measurement. The company also manufactures thousands of ELISA kits for human research and preclinical/animal testing across 20+ species (mouse, rat, dog, cat, primate, bovine, porcine, avian, and others). Secondary offerings include 1,300+ monoclonal and polyclonal antibodies; 200+ biochemicals (recombinants, substrates, inhibitors, polymerases); and laboratory testing services for lipid and vitamin C analysis. Several assays carry regulatory status for clinical diagnostics (ISO 13485, CE Mark), while others are designated research-use-only in the US. The company also produces animal assay reagents for veterinary diagnostics (dog CRP, cat serum amyloid A) and has developed COVID-19 response reagents. Founded in 1983, Kamiya serves clinical laboratories, research institutions, and preclinical/pharmaceutical development markets. Manufacturing capabilities include custom antibody production, ELISA kit formulation, and reagent adaptation to third-party chemistry analyzer platforms.

LuxCreo Inc. is a dental technology company headquartered in Chicago, Illinois, specializing in high-speed 3D printing systems and integrated digital dentistry solutions. The company manufactures the iLux Pro Dental, claimed as the #1 dental 3D printer globally, alongside post-processing equipment (iLuxWash Dental automated cleaning and iLuxCure Pro Dental UV curing units). LuxCreo's product portfolio includes direct-printed orthodontic aligners (4D Aligner™, 4D Bright™), prosthodontic devices (nightguards, flexible partial dentures, dentures), restorative solutions (crowns, bridges, inlays/onlays), and dental models. The company develops proprietary materials including ActiveMemory™ Polymer, a shape-memory resin designed for superior patient comfort in clear aligner therapy. LuxCreo's software ecosystem comprises LuxFlow Pro (3D printing preparation), LuxDesign (AI-powered design automation), LuxLink (fleet management and monitoring), and LuxCloud Dental (integrated digital dentistry platform). Services include 4D Express™ (aligner design and manufacturing), installation and training, and technical support. The company serves both chairside clinical practices and laboratory-scale operations, with markets spanning North America, Europe, and APAC. LuxCreo positions itself at the intersection of clinical dentistry and manufacturing automation, targeting orthodontists, prosthodontists, and dental laboratories seeking to integrate digital workflows and same-day device fabrication.

Biolog, Inc. is a life sciences company specializing in microbial identification, characterization, and enumeration tools and services for research, diagnostics, quality control, and industrial applications. The company manufactures microarray-based phenotypic identification platforms, anaerobic culture systems, and metabolic profiling instruments used by academic researchers, clinical laboratories, pharmaceutical firms, food safety testing, and water quality monitoring operations. Core product lines include the Odin cellular analysis system, ID Station (microbial identification), Anaerobic Chambers with TruPRAS media (for culturing fastidious anaerobes), Phenotype MicroArray (PM) plates for bacterial phenotyping, Microbial Identification Microplates (GEN III, Filamentous Fungi), Community Analysis Microplates (EcoPlate, PreBioM, RhizoPlates), and reagent kits. Biolog Lab Services offers multiomic microbial identification, enumeration, phenotype analysis, anaerobic cultivation, USP <797> testing, foodborne pathogen detection, and water microbiology testing. The company holds ISO 17025:2017 accreditation, FDA registration, and GDUFA compliance. Anaerobe Systems, a 45-year anaerobic culture leader acquired by Biolog, achieved EU IVDR CE marking and now serves diagnostic clinics worldwide. Applications span basic research, drug discovery, agricultural microbiology, food safety, clinical diagnostics, and bioproduct development.

Vesco Devices specializes in microbiology laboratory testing equipment and consumables. The company offers membrane filtration sterility test kits, sterile IPA sprayers, and pre-saturated wipes designed for microbiology labs. Vesco positions itself as a quality alternative to established brands, emphasizing competitive pricing, product innovation, and customization of product quantities and sizes to meet laboratory requirements. The company serves clinical and research laboratories requiring microbiology testing supplies and sterilization/disinfection consumables.

Calbiotech, Inc. is an FDA-registered, ISO 13485-certified contract development and manufacturing organization (CDMO) specializing in immunoassay development and production for diagnostic and research applications. Based in El Cajon, California, the company brings 25+ years of in-vitro diagnostics (IVD) expertise to support diagnostics innovation from assay design through commercial scale-up. Calbiotech develops and manufactures over 200 ready-to-use ELISA kits covering clinical diagnostics (cardiac markers, diabetes, infectious disease, cancer markers, allergy, autoimmune disorders) and preclinical research (mouse/rat biomarkers, neonatal screening). Core CDMO services include custom assay design and optimization, contract manufacturing with scalable batch sizes, reagent formulation and fill-finish, biomarker validation, regulatory pathway support (LDT, RUO, IVD), and quality/compliance documentation under cGMP standards. The company also manufactures monoclonal antibodies in a dedicated GMP facility. Calbiotech serves a global customer base across 50-80 countries, offering U.S. manufacturing origin, local manufacturing partnerships, and regulatory support for market access.

ScyTek Laboratories is a Utah-based diagnostic reagent manufacturer with 30+ years of expertise in producing high-quality laboratory consumables and specialty products. The company specializes in histology stains, immunohistochemistry (IHC) reagents, hematology products, microbiology reagents, and primary antibodies for clinical and research laboratories. ScyTek manufactures special stains including Gomori Methenamine-Silver (GMS), Periodic Acid stains, Martius Scarlet Blue (MSB), and Trichrome formulations. The product portfolio encompasses ancillary reagents, transport media, buffers, cytology nuclear stains, and ELISA components. ScyTek offers OEM and private-label manufacturing capabilities, custom formulation and packaging services, as well as warehousing and drop-shipping solutions. The company serves pathology laboratories, hospital anatomy departments, and life sciences research institutions with regulated, quality-assured diagnostic reagents.

Vistapath Biosystems is a software-focused medical technology company headquartered in Cambridge, MA. The company develops Sentinel, an end-to-end digital grossing platform designed to modernize pathology laboratory workflows. Sentinel automates and optimizes critical lab processes including tissue specimen grossing, enhancing quality, efficiency, and consistency across commercial laboratories, hospital pathology labs, contract research organizations (CROs), and life sciences companies. The platform leverages artificial intelligence to streamline intraoperative and routine pathology operations. Vistapath collaborates with established diagnostic and pathology partners (PathAI, Gestalt Diagnostics, PathGroup, Freedom Pathology Laboratories) to validate and deploy the Sentinel platform across clinical and research settings. The company targets mid- to large-scale pathology operations seeking digitization and workflow automation. Management includes CEO Tim Spong and VP Sales & Marketing J. Fernando Corredor, who brings over 20 years of medical device industry experience including work with acquired companies (Medtronic, Integra LifeSciences, Samsung) in imaging and AI-driven diagnostics. While regulatory certifications are not explicitly mentioned in available materials, the company's clinical deployment trajectory and partnership with established pathology networks indicate compliance with relevant healthcare software standards.

FHC, Inc. is a specialized medical device manufacturer based in Bowdoin, Maine, founded in 1970. The company focuses on neuroscience and neurosurgery solutions, particularly cranial microtargeting and neuromodulation. FHC designs and manufactures microelectrodes, electrode positioning systems, stereotactic platforms, and surgical planning software for both clinical and research applications. Their clinical product line includes the Guideline 5 Neuromodulation System, STarFix Stereotactic Platforms, STar Microdrive System, and WayPoint Navigation software for surgical planning. The research division offers NeuroCraft microelectrodes and insertion tubes for neurophysiology studies. FHC's solutions support therapeutic interventions including deep brain stimulation, ablation, resection, and treatment of movement disorders such as Parkinson's Disease, epilepsy, dystonia, and essential tremor. The company also provides stereoelectroencephalography (SEEG) equipment and operates Greenville Neuromodulation Services for DBS research and surgeon training. With approximately 170 employees and estimated annual revenue of $42.6 million, FHC serves neurosurgical centers and research institutions globally.

AdvanBio is a U.S.-based biotechnology research company (subsidiary of Autobio Diagnostics) headquartered in Irvine, California. The company specializes in advancing medical laboratory technology for precision medicine and patient diagnostics. AdvanBio provides comprehensive services including bioanalysis with advanced sample evaluation capabilities, assay development and validation for in vitro diagnostics (IVD) and molecular diagnostics assays, and regulatory consultation to navigate complex global compliance requirements. The company has introduced Autobio/BioYuan quality control products to the U.S. market—essential calibration and verification tools for ensuring diagnostic test accuracy and improving patient care outcomes. With expertise in biomarker development, diagnostic platform integration, and biological molecule analysis, AdvanBio serves laboratory and diagnostic manufacturers seeking innovation, regulatory expertise, and supply chain stability.

Vitang Technology LLC is a digital dentistry solutions provider specializing in clear aligner manufacture, 3D printing services, and guided surgical implant solutions. The company operates under the UNISMILE™ brand for clear aligner products, positioning itself as a low-cost, high-quality alternative with fast turnaround times. Core service offerings include: (1) Clear Aligner Systems—UNISMILE™ aligners for orthodontic correction; (2) 3D Printing Services—encompassing scan acquisition, digital design, and additive manufacturing of dental models and surgical guides; (3) Guided Implant Surgery Solutions—comprehensive A-to-Z implant planning and surgical guide fabrication. The company targets dental practices, orthodontists, and implant surgeons seeking digital workflow integration and cost-effective manufacturing. Vitang positions digital dentistry adoption as central to modern practice efficiency. No specific regulatory certifications, FDA clearances, or ISO standards are mentioned on the available website content, though dental clear aligners and surgical guides typically require FDA 510(k) clearance or equivalent regulatory approval.

ARX Sciences is a specialized manufacturer and distributor of in vitro diagnostic reagents and biologicals based in Buffalo, New York. The company manufactures coagulation controls, microbiological transport media, and markets validated antibodies and recombinant proteins for research and clinical diagnostics. ARX operates cGMP-certified, ISO 13485-compliant, FDA-registered manufacturing facilities offering custom formulation development, contract manufacturing with flexible lot sizes, and proprietary formulation support. Core product lines include primary and secondary antibodies for ELISA, Western blot, immunohistochemistry, immunoprecipitation, and immunofluorescence applications; recombinant proteins such as human growth hormone; and EUA-authorized viral and bacterial transport media for specimen collection and preservation. The company provides end-to-end transparency in custom manufacturing, rapid turnaround (4–8 weeks), and integrated quality testing for diagnostic assay development and production.

Molecular Testing Labs is a CLIA-certified and CAP-accredited clinical laboratory operating facilities in Vancouver, WA (CLIA# 50D2050397, CAP# 8690528) and Irving, TX (CLIA# 45D2278063, CAP# 9607237). The company processes hundreds of thousands of diagnostic tests monthly on both clinically and non-clinically collected samples. Their scientific team includes world-class clinicians, PhDs, research scientists, and diagnostic technicians focused on advancing diagnostic accessibility and equity in healthcare. MLT offers end-to-end diagnostic services across multiple therapeutic and clinical areas. Core service lines include comprehensive drug testing and toxicology screening with confirmation methodologies, GLP-1 weight management adherence testing using advanced diagnostics to monitor treatment efficacy, and population health testing solutions designed to close care gaps and improve health outcomes. They provide tailored solutions for diverse markets including clinics, digital health companies, public health departments, research universities, and telehealth platforms. The company emphasizes quality systems, compliance leadership, and patient-centered diagnostics. Their operations include sample logistics, specimen handling, and results reporting integrated with clinical workflows. MTL maintains rigorous quality measures, continuous compliance training, and auditing protocols. The organization is committed to making diagnostic care accessible while maintaining stringent regulatory adherence and ethical standards across all testing operations.

Eiger Diagnostics, Inc. is a clinical diagnostic company specializing in parasitology and infectious disease testing products. The company manufactures and distributes parasitic serology assays and related diagnostic products for laboratory use. Founded to provide high-quality, low-cost diagnostic solutions, Eiger Diagnostics serves laboratory communities globally. The company has acquired product lines previously offered through IVD Research Inc. and New Life Diagnostics, consolidating expertise in parasitic serology and infectious disease diagnostics. The company indicates planned portfolio expansion in subsequent years. Eiger Diagnostics positions itself as a provider of in vitro diagnostic (IVD) products designed for clinical laboratories, with a focus on accessibility and quality in parasitology and infectious disease testing.

Springside Scientific LLC is a Durham, NC-based laboratory services provider specializing in the manufacture and curation of custom human tissue control slides for pathology, immunohistochemistry (IHC), and diagnostic applications. The company operates a 3,500 sq ft laboratory facility and maintains an extensive tissue repository of over 40,000 tissue blocks, enabling rapid fulfillment of routine orders and same-day shipping. Core capabilities include custom control slide preparation, IHC microarrays, tailored tissue placement and selection, and comprehensive pathology reporting. The company's leadership includes two PhD-level scientists. Springside also offers private-label and white-label programs for dealers and distributors, allowing partners to brand custom-designed or co-developed tissue control products under their own labels. The company supports research institutions, diagnostic laboratories, and commercial pathology operations with quality-assured control materials essential for assay validation, quality control, and regulatory compliance in clinical and research pathology workflows.

Affinity Biosensors develops rapid microbial identification and antibiotic susceptibility testing (AST) systems for clinical laboratory use. The flagship LifeScale AST system delivers Gram-negative bacterial identification and resistance profiling in 4.5 hours—significantly faster than standard methods—with accuracy matching traditional standards of care. The system features automated sample preparation, inoculation, incubation, and reporting, requiring minimal hands-on time (<5 minutes) and technician training. LifeScale operates with a room-temperature-stable kit containing all consumables for single assays, automatic 96-well plate inoculation, and capacity to process up to 5 samples simultaneously. FDA-cleared for blood culture identification and AST, it integrates into existing laboratory workflows alongside rapid blood culture identification systems. Clinical validation across multiple sites and organism types (E. coli, Klebsiella, Pseudomonas, Acinetobacter) demonstrates essential and categorical agreement comparable to or better than WalkAway, Phoenix, and VITEK systems, with reduced error rates critical for antimicrobial stewardship.

Volu-Sol Inc. is a laboratory consumables manufacturer specializing in diagnostic stains and reagents for clinical and veterinary pathology. The company offers a comprehensive portfolio of histology, hematology, cytology, and microbiology stains including Wright-Giemsa, Gram stain, Lactophenol Cotton Blue, and May-Grunwald formulations. They manufacture both manual dip-stain kits and validated stain packs optimized for automated staining systems (stainer-agnostic platforms). Volu-Sol produces the Definitive DCM, an automated benchtop slide stainer optimized for digital cell morphology (DCM) and computer-aided image recognition. The company also supplies high-purity ethanol products in multiple grades (200 Proof ACS/USP, Specially Denatured Alcohol 40-B, Completely Denatured Alcohol 12-A) for laboratory and industrial use, continuing a product line since 1970. Products are distributed through major medical-laboratory channels including Thermo Fisher Scientific, Medline, Cardinal Health, McKesson, and MWI Veterinary Supply. The company serves clinical laboratories, veterinary diagnostic facilities, and research institutions.

Sterility Assurance Laboratories, Inc. is a contract testing and validation laboratory specializing in sterilization services and microbial testing for medical device manufacturers. The company provides comprehensive sterilization validation and sterility testing services for medical devices processed via ethylene oxide (EO) and other sterilization methods. Core service offerings include Medical Device Sterilization support, Sterilization Validation studies, Sterility Testing (USP <71>), Bioburden determination, and Microbial Limits testing. Additionally, SAL offers specialized analytical services including Ethylene Oxide Residuals testing and Dialysis Water and Dialysate Testing, supporting both device manufacturers and dialysis facility operations. The laboratory serves medical device manufacturers requiring regulatory-compliant testing to support FDA submissions, 510(k) clearances, and ongoing quality assurance. Services are aligned with industry standards including USP, ISO, and FDA guidance for sterilization validation and microbial control. The company operates a full-service laboratory facility capable of supporting device development, validation, and quality testing throughout the product lifecycle.

SINTX Technologies is a advanced ceramics manufacturer specializing in silicon nitride (Si3N4) biomaterials and composite 3D printing. Founded in 1996, the company produces medical-grade silicon nitride for spinal implants, hip and knee joint prosthetics, and foot-and-ankle fusion systems. Silicon nitride is inherently antibacterial and antiviral with demonstrated osseointegrative properties to support bone formation. SINTX manufactures composite 3D-printed medical devices and offers silicon nitride powder (FleX SN-AP) for use as additives, coatings, or composites in medical and non-medical products to enhance antipathogenic properties. The company has expanded into manufacturing other advanced ceramics and recently partnered with EVONIK to produce silicon nitride–PEEK (SiN/PEEK) composite materials engineered for AI-assisted, 3D-printed patient-specific implants. SINTX also acquired SiNAPTIC Surgical assets to enter the foot-and-ankle fusion market. The company holds ISO 13485:2016 certification for medical device manufacturing, ISO 9001:2015 certification, and AS9100D certification for aerospace-grade manufacturing. SINTX is a publicly traded company (NASDAQ) and member of AdvaMed, BioUtah, and other industry associations. Manufacturing and engineering capabilities support transformation of concepts into quality printed parts with extreme environment performance suitable for biomedical applications.

Rad Source Technologies is a global manufacturer of X-ray-based irradiation systems for life science research, medical treatment, and industrial applications. The company specializes in non-nuclear irradiator solutions serving diverse markets including blood bank operations, preclinical research, cell culture, cannabis decontamination, nondestructive testing (NDT), and sterile insect technique (SIT) programs. Product portfolio includes the RS 3400 blood irradiator (featuring industry-leading dose uniformity), RS 2000 Q2 small animal research system, RS 1800 Q cell irradiator, RS 2400 Q sterile insect technique system, RS 420 Q+ BOOST cannabis decontamination platform, and NDT 1000 materials inspection imaging system. The company emphasizes X-ray technology as a non-radioactive alternative to gamma irradiation, positioning its systems for regulatory compliance and operational safety. Rad Source maintains a global service and support network with trained technicians for equipment maintenance, calibration, and technical support. The organization serves research institutions, blood banks, cannabis producers, and industrial inspection operations. All systems are designed for dose uniformity, throughput optimization, and application-specific customization. The company publishes peer-reviewed research on X-ray irradiation efficacy and hosts educational webinars on microbial remediation and contamination control.

Biorep Technologies is an ISO 13485-certified, FDA-registered medical device contract design and manufacturing organization (CDMO) based in Miami Lakes, Florida. Founded in 1994, the company specializes in end-to-end medical device development and manufacturing services, including rapid prototyping, design verification, process development and validation, contract manufacturing, and assembly services. With over 30 years of experience, Biorep serves medical device companies across cardiovascular, minimally invasive surgical instruments, ENT devices, and diabetes research equipment sectors. The company maintains a vertically integrated structure with capabilities spanning concept through scale-up, production launch, and lifecycle support. Biorep partners with global med-tech innovators and maintains a strategic partnership with the Diabetes Research Institute, providing essential research equipment for type I diabetes initiatives. The company operates with documented design controls, traceability systems, supply chain management, and regulatory compliance infrastructure compatible with US, EU, and Asian markets.

CLINIQA Corporation is a clinical diagnostics manufacturer with over 40 years of industry experience, specializing in in-vitro diagnostic (IVD) products and biological materials for clinical laboratories. The company manufactures a comprehensive portfolio of quality controls, calibrators, calibration verifiers, and reagents available in liquid, lyophilized, and powder formats. CLINIQA supplies bulk purified proteins, enzymes, disease-state plasmas, infectious disease antigens, and processed serums to diagnostic laboratories globally. The company operates a cGMP-compliant manufacturing facility and offers custom formulation and contract manufacturing services for diagnostic assay development. Product formats feature extended refrigerated stability for liquid preparations. CLINIQA maintains ISO 13485:2016, EN ISO 13485:2016, and MDSAP certifications, demonstrating regulatory compliance across multiple markets. The company employs FDA-compliant, phase-based Design Control processes for product development spanning research through commercial launch. Distribution is supported by a comprehensive network serving diagnostic laboratory customers worldwide.

Dakewe Biotech Co., Ltd. is a Chinese life sciences and biomedical company founded in 1999, headquartered in Shenzhen with branch offices in Beijing, Shanghai, Guangzhou, Chengdu, Wuhan, and Hong Kong. The company operates across two primary segments: bioscience and biomedicine. The bioscience division develops and manufactures scientific instruments and life science research reagents. The biomedicine division produces medical devices and diagnostic reagents for clinical and laboratory use. As of mid-2022, the company employs approximately 750+ personnel, with 59% holding bachelor's degrees or higher. Dakewe maintains business relationships with over 100 foreign biotech companies and thousands of domestic clients. Products are distributed to Hong Kong, Taiwan, Southeast Asia, and North America. The company's core business encompasses research-grade instrumentation, diagnostic reagents, and medical equipment serving both research institutions and clinical laboratories. Quality, service, and innovation are stated operational priorities.

Covaris, LLC is a life sciences instrumentation and consumables company specializing in acoustic focused acoustic (AFA) technology for sample preparation and biomolecule extraction. The company designs and manufactures instruments, kits, reagents, and consumables for DNA/RNA shearing, chromatin preparation, proteomics, cell lysis, and FFPE (formalin-fixed paraffin-embedded) tissue extraction. Their product portfolio supports applications in next-generation sequencing (NGS), genomics, proteomics, and clinical/research workflows. Covaris offers both off-the-shelf instruments and kits as well as custom service capabilities including FFPE extraction services, sample preparation and nucleic acid shearing services, and custom development projects. The truCOLLECT Solution represents their recent entry into decentralized blood collection with integrated DNA extraction for clinical research and biopharma applications. The company serves research laboratories, clinical diagnostics, and biopharma organizations. Covaris maintains comprehensive technical support including protocols, user manuals, software downloads, and participates in major life sciences conferences and events.

ScheBo Biotech AG is an innovative biotechnology company specializing in the development, production, and marketing of in-vitro diagnostics (IVD). Founded by biochemists Dr. Ursula Scheefers-Borchel and Dr. Hans Scheefers, the company has built over 35 years of expertise delivering unique, clinically validated diagnostic solutions. ScheBo's product portfolio addresses four key clinical specialties: gastroenterology (gastrointestinal disease diagnostics), oncology (cancer diagnostics), veterinary diagnostics, and SARS-CoV-2 diagnostics. The company is internationally active with headquarters in Germany and offices in the USA and UK. ScheBo emphasizes innovation through clinical research and development, positioning its products as gold-standard diagnostic tools with strong unique selling propositions. The company serves clinical laboratories, hospitals, and diagnostic centers globally.